Professor Michael Sherburn, from the Research School of Chemistry
via ANU
Chemists have developed a revolutionary new way to manufacture natural chemicals by clipping smaller molecules together like Lego. They have used the new method to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria, pseudopterosin.
“We took small molecules and clipped them together like Lego,” said lead researcher Professor Michael Sherburn, from the Research School of Chemistry.
“The building blocks are carefully designed in such a way that the first reaction generates a product perfectly primed for the second. It’s quite magical. This means you can efficiently build large and complex molecules.”
Medicines of this type have traditionally been made in a cumbersome way. Chemists take a related molecule and renovate it. This is a lengthy process, with unwanted structural features being ripped out and replaced.
“This leads to a lot of waste,” Professor Sherburn said.
The group trialed their innovative new method by making pseudopterosin, a powerful anti-inflammatory and analgesic drug, which is currently only available in tiny quantities extracted from fan coral found in the Bahamas.
The work began as blue-sky research, with the researchers trying to work out a way to make supposedly impossible molecules of cross-conjugated hydrocarbons.
Before trying the experiments the team ran simulations on the Raijin supercomputer, which indicated that their method had potential.
“Ours is an empowering and enabling technique, allowing a smarter and faster way to make important substances,” said Dr Chris Newton, who did the research in the laboratory as a PhD student.
The Latest on: Manufacturing new drugs
via Google News
The Latest on: Manufacturing new drugs
- Be Bio and Resilience Announce Strategic Collaboration to Manufacture Engineered B Cells, a New Class of Cellular Medicineson May 19, 2022 at 3:30 am
Be Biopharma and National Resilience today announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline.
- Drug Discovery Services Market Industry Key Players, Trends, Sales, Supply, Demand, Analysis and Forecast to 2025on May 18, 2022 at 10:44 pm
Snapshot The global drug discovery services market is thriving on account of the rising impetus given to research ...
- Immunology Drug Market Competitive Landscape and Strategies of for New Companies with Fastest Growing Regions with new Opportunitieson May 18, 2022 at 9:52 pm
May 19, 2022 (The Expresswire) -- ""Immunology Drug Market"" Insights 2022 By Types (Monoclonal Antibodies (mAb), Antibody Drug Conjugates, ...
- OTC Drug Market with Strong Focus on Industry Size, by Financial Highlights, Market Segments, Growth Rate, Revenue, and Forecast to 2026on May 18, 2022 at 9:29 pm
May 19, 2022 (The Expresswire) -- ""OTC Drug Market"" Insights 2022 By Types ( Class A, Class B), Applications (HospitalClinicHousehold), Regions ...
- Two Rutgers engineers create analytical tool to accelerate the production of biologic drugson May 18, 2022 at 6:44 pm
Two Rutgers engineers specializing in the process of making drugs derived from living organisms have created an analytical tool they expect will accelerate the discovery and production of biologic ...
- Engineering team creates monitoring toolkit to speed production of biologic drugson May 18, 2022 at 12:30 pm
Two Rutgers University engineers specializing in the process of making drugs derived from living organisms have created an analytical tool they expect will accelerate the discovery and production of ...
- Rutgers Pair Creates Monitoring Toolkit to Speed Production of Biologic Drugson May 18, 2022 at 11:38 am
Two Rutgers engineers specializing in the process of making drugs derived from living organisms have created an analytical tool they expect will accelerate the discovery and production of biologic ...
- AffyXell Expands Manufacturing Partnership with GenScript ProBioon May 18, 2022 at 5:12 am
Will develop next generation cell and gene therapies based on mesenchymal stem cells which incorporate Affimer immunotherapies.
- Uganda to start manufacturing cancer drugson May 13, 2022 at 5:00 pm
Uganda has embarked on manufacturing its own cancer drugs, with the first batch expected to hit the market in July this year. ;The drugs, to be produced by Cipla Quality Chemical Industries under the ...
- Pharmaceutical Contract Manufacturing Market Report 2022-2032on May 12, 2022 at 2:19 am
Forecasts by Services (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Drug Development Services, Biologics Contract ...
via Bing News
